Valuation : Baxter International Inc.

Market Cap 13.7B 11.76B 11.04B 10.08B 19.02B 1,307B 19.12B 131B 50.62B 659B 51.44B 50.32B 2,183B P/E 2026 *
34x
P/E 2027 * 22.1x
Enterprise Value 20.6B 17.68B 16.59B 15.16B 28.6B 1,965B 28.74B 196B 76.1B 991B 77.34B 75.66B 3,283B EV / Sales 2026 *
1.77x
EV / Sales 2027 * 1.69x
Free-Float
75.38%
Yield 2026 *
0.15%
Yield 2027 * 0.15%
1 day+0.80%
1 week-0.53%
Current month+1.30%
1 month+18.30%
3 months+36.74%
6 months+30.16%
Current year+38.67%
1 week 26.01
Extreme 26.01
26.76
1 month 23.58
Extreme 23.575
30
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 2025-07-31
Director of Finance/CFO 52 2026-03-15
Chief Tech/Sci/R&D Officer 57 2023-12-31
Director TitleAgeSince
Director/Board Member 66 2019-02-17
Director/Board Member 65 2018-12-31
Director/Board Member 69 2021-02-14
Date Insider Type Main position Quantity % Market Cap.
5/5/26 Free

Director

12,836 0.0025%
2/27/26 Free

Chief Executive Officer

690,310 0.1343%
2/27/26 Free

General Counsel

92,700 0.0180%
Change 5-day change 1-year change 3-year change Capi.($)
+0.80%-0.53%+8.16%-36.19% 13.7B
-1.75%-0.29%-13.29%+9.49% 197B
+0.97%-2.24%-0.17%+11.96% 118B
-0.08%+3.37%+13.15%+82.63% 62.55B
-2.00%-3.74%+27.02%+53.48% 52.4B
+0.23%+1.39%-1.99%-32.07% 51.81B
-0.22%-1.02%+16.87%-11.71% 33.57B
-2.97%+1.98% - - 30.34B
+0.41%-0.81%+43.12%-11.13% 24.63B
-0.47%+3.56%-3.25%+19.21% 23.81B
Average -0.70%+0.55%+9.96%+9.52% 60.8B
Weighted average by Cap. -1.06%-0.00%+2.00%+15.38%

Financials

2026 *2027 *
Net sales 11.62B 9.97B 9.36B 8.55B 16.13B 1,108B 16.21B 111B 42.92B 559B 43.62B 42.67B 1,851B 11.86B 10.18B 9.56B 8.73B 16.47B 1,131B 16.55B 113B 43.83B 571B 44.54B 43.58B 1,891B
Net income 372M 319M 300M 274M 517M 35.48B 519M 3.55B 1.37B 17.9B 1.4B 1.37B 59.29B 687M 590M 554M 506M 955M 65.57B 959M 6.55B 2.54B 33.08B 2.58B 2.53B 110B
Net Debt 6.9B 5.92B 5.56B 5.07B 9.58B 658B 9.62B 65.75B 25.48B 332B 25.9B 25.33B 1,099B 6.32B 5.42B 5.09B 4.65B 8.77B 602B 8.81B 60.22B 23.34B 304B 23.72B 23.2B 1,007B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change
26-08-26 US$26.50 +0.80%
26-08-25 US$26.29 -0.76%
26-08-24 US$26.49 +0.57%
26-08-21 US$26.34 -0.27%
26-08-20 US$26.41 -0.86%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
26.50USD
Average target price
28.73USD
Spread / Average Target
+8.40%

Quarterly revenue - Rate of surprise